Ameliorative effects of baicalein in MPTP-induced mouse model of Parkinson's disease: A microarray study

Pharmacology Biochemistry and Behavior

Volumn 133, Issue , 2015, Pages 155-163

  Gao, Li ^a,b   Li, Chao ^a   Yang, Ran Yao ^a   Lian, Wen Wen ^a   Fang, Jian Song ^a   Pang, Xiao Cong ^a   Qin, Xue Mei ^b   Liu, Ai Lin ^a,c   Du, Guan Hua ^a,d  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b SHANXI UNIVERSITY   (China)

^c Beijing Key Laboratory of Drug Target Research and Drug Screening   (China)

^d State Key Laboratory of Bioactive Substance and Function of Natural Medicines   (China)

Author keywords

Baicalein; Biological process; Gene expression; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BAICALEIN; BENSERAZIDE PLUS LEVODOPA; COMPLEMENTARY DNA; LIM KINASE 1; NEUROTROPHIN; DOPAMINE; FLAVANONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BIOINFORMATICS; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION; INVESTIGATIVE PROCEDURES; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROBLAST; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; WALKING; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; MOTOR ACTIVITY; PARKINSON DISEASE, SECONDARY; PATHOPHYSIOLOGY; ROTAROD TEST; SIGNAL TRANSDUCTION;

MUS; SCUTELLARIA BAICALENSIS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOPAMINE; FLAVANONES; GENE EXPRESSION; MALE; MICE; MOTOR ACTIVITY; NEUROGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE, SECONDARY; ROTAROD PERFORMANCE TEST; SIGNAL TRANSDUCTION;

EID: 84928554304     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.04.004     Document Type: Article

References (67)

1. J.E. Ahlskog, and M.D. Muenter Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 2001 448 458
2. T. Archer, and A. Fredriksson Physical exercise attenuates MPTP-induced deficits in mice Neurotox Res 18 2010 313 327
3. R.J. Armstrong, and R.A. Barker Neurodegeneration: a failure of neuroregeneration? Lancet 358 2001 1174 1176
4. A.L. Barabasi, and Z.N. Oltvai Network biology: understanding the cell's functional organization Nat Rev Genet 5 2004 101 113
5. K. Bossers, G. Meerhoff, R. Balesar, J.W. van Dongen, C.G. Kruse, and D.F. Swaab Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death Brain Pathol 19 2009 91 107
6. F. Cesca, A. Yabe, B. Spencer-Dene, J. Scholz-Starke, L. Medrihan, and C.H. Maden Kidins220/ARMS mediates the integration of the neurotrophin and VEGF pathways in the vascular and nervous systems Cell Death Differ 19 2012 194 208
7. B.C. Chan, M. Ip, C.B. Lau, S.L. Lui, C. Jolivalt, and C. Ganem-Elbaz Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase J Ethnopharmacol 137 2011 767 773
8. Y. Cheng, G. He, X. Mu, T. Zhang, X. Li, and J. Hu Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile Neurosci Lett 441 2008 16 20
9. P.D. Chowdary, D.L. Che, and B. Cui Neurotrophin signaling via long-distance axonal transport Annu Rev Phys Chem 63 2012 571 594
10. K. Gasiorowski, E. Lamer-Zarawska, J. Leszek, K. Parvathaneni, B.B. Yendluri, and Z. Blach-Olszewska Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? CNS Neurol Disord Drug Targets 10 2011 184 191
11. S. Genc, F. Kuralay, K. Genc, M. Akhisaroglu, S. Fadiloglu, and K. Yorukoglu Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production Neurosci Lett 298 2001 139 141
12. M. Geraerts, O. Krylyshkina, Z. Debyser, and V. Baekelandt Concise review: therapeutic strategies for Parkinson disease based on the modulation of adult neurogenesis Stem Cells 25 2007 263 270
13. Y. Guo, S. Liu, X. Zhang, L. Wang, X. Zhang, and A. Hao Sox11 promotes endogenous neurogenesis and locomotor recovery in mice spinal cord injury Biochem Biophys Res Commun 446 2014 830 835
14. A. Haslinger, T.J. Schwarz, M. Covic, and D.C. Lie Expression of Sox11 in adult neurogenic niches suggests a stage-specific role in adult neurogenesis Eur J Neurosci 29 2009 2103 2114
15. X.J. He, H. Yamauchi, K. Uetsuka, and H. Nakayama Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease Neurotoxicology 29 2008 413 420
16. J.M. Hebert, M. Lin, J. Partanen, J. Rossant, and S.K. McConnell FGF signaling through FGFR1 is required for olfactory bulb morphogenesis Development 130 2003 1101 1111
17. J.D. Hoheisel Microarray technology: beyond transcript profiling and genotype analysis Nat Rev Genet 7 2006 200 210
18. J.M. Itier, P. Ibanez, M.A. Mena, N. Abbas, C. Cohen-Salmon, and G.A. Bohme Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Hum Mol Genet 12 2003 2277 2291
19. V. Jackson-Lewis, J. Blesa, and S. Przedborski Animal models of Parkinson's disease Parkinsonism Relat Disord 18 Suppl. 1 2012 S183 S185
20. J. Jankovic Parkinson's disease: clinical features and diagnosis J Neurol Neurosurg Psychiatry 79 2008 368 376
21. M. Jiang, Y. Porat-Shliom, Z. Pei, Y. Cheng, L. Xiang, and K. Sommers Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism J Neurochem 114 2010 419 429
22. K.A. Kang, R. Zhang, M.J. Piao, S. Chae, H.S. Kim, and J.H. Park Baicalein inhibits oxidative stress-induced cellular damage via antioxidant effects Toxicol Ind Health 28 2012 412 421
23. I.K. Lee, K.A. Kang, R. Zhang, B.J. Kim, S.S. Kang, and J.W. Hyun Mitochondria protection of baicalein against oxidative damage via induction of manganese superoxide dismutase Environ Toxicol Pharmacol 31 2011 233 241
24. A. Lesemann, C. Reinel, P. Huhnchen, M. Pilhatsch, R. Hellweg, and P. Klaissle MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice Brain Res 1457 2012 51 69
25. T.G. Lesnick, S. Papapetropoulos, D.C. Mash, J. Ffrench-Mullen, L. Shehadeh, and M. de Andrade A genomic pathway approach to a complex disease: axon guidance and Parkinson disease PLoS Genet 3 2007 e98
26. X.X. Li, G.R. He, X. Mu, B. Xu, S. Tian, and X. Yu Protective effects of baicalein against rotenone-induced neurotoxicity in PC12 cells and isolated rat brain mitochondria Eur J Pharmacol 674 2012 227 233
27. C.C. Lin, and D.E. Shieh The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin Am J Chin Med 24 1996 31 36
28. R. Liu, M. Gao, G.F. Qiang, T.T. Zhang, X. Lan, and J. Ying The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit Neuroscience 162 2009 1232 1243
29. C. Lopez-Menendez, S. Gascon, M. Sobrado, O.G. Vidaurre, A.M. Higuero, and A. Rodriguez-Pena Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways J Cell Sci 122 2009 3554 3565
30. D.W. Luchtman, D. Shao, and C. Song Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease Physiol Behav 98 2009 130 138
31. I. Martin, V.L. Dawson, and T.M. Dawson Recent advances in the genetics of Parkinson's disease Annu Rev Genomics Hum Genet 12 2011 301 325
32. L. Matsumoto, H. Takuma, A. Tamaoka, H. Kurisaki, H. Date, and S. Tsuji CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease PLoS One 5 2010 e15522
33. W.G. Meissner, M. Frasier, T. Gasser, C.G. Goetz, A. Lozano, and P. Piccini Priorities in Parkinson's disease research Nat Rev Drug Discov 10 2011 377 393
34. G.E. Meredith, and U.J. Kang Behavioral models of Parkinson's disease in rodents: a new look at an old problem Mov Disord 21 2006 1595 1606
35. R.M. Miller, L.L. Chen, G.L. Kiser, T.L. Giesler, T.M. Kaysser-Kranich, and C. Palaniappan Temporal evolution of mouse striatal gene expression following MPTP injury Neurobiol Aging 26 2005 765 775
36. R.M. Miller, G.L. Kiser, T.M. Kaysser-Kranich, R.J. Lockner, C. Palaniappan, and H.J. Federoff Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease Neurobiol Dis 21 2006 305 313
37. I. Mocchetti, and M. Brown Targeting neurotrophin receptors in the central nervous system CNS Neurol Disord Drug Targets 7 2008 71 82
38. N. Moisoi, K. Klupsch, V. Fedele, P. East, S. Sharma, and A. Renton Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response Cell Death Differ 16 2009 449 464
39. L.B. Moran, D.C. Duke, M. Deprez, D.T. Dexter, R.K. Pearce, and M.B. Graeber Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease Neurogenetics 7 2006 1 11
40. X. Mu, G. He, Y. Cheng, X. Li, B. Xu, and G. Du Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro Pharmacol Biochem Behav 92 2009 642 648
41. X. Mu, G.R. He, X. Yuan, X.X. Li, and G.H. Du Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice Pharmacol Biochem Behav 98 2011 286 291
42. P. Navarro, R. Guerrero, E. Gallego, J. Avila, R. Luquin, and P.J. Garcia Ruiz Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau J Neurol Sci 275 2008 139 144
43. M. O'Donnell, C.S. Hong, X. Huang, R.J. Delnicki, and J.P. Saint-Jeannet Functional analysis of Sox8 during neural crest development in Xenopus Development 133 2006 3817 3826
44. N. Ogawa, Y. Hirose, S. Ohara, T. Ono, and Y. Watanabe A simple quantitative bradykinesia test in MPTP-treated mice Res Commun Chem Pathol Pharmacol 50 1985 435 441
45. S.B. Oh, H.R. Park, Y.J. Jang, S.Y. Choi, T.G. Son, and J. Lee Baicalein attenuates impaired hippocampal neurogenesis and the neurocognitive deficits induced by gamma-ray radiation Br J Pharmacol 168 2013 421 431
46. G. Rozas, M.J. Guerra, and J.L. Labandeira-Garcia An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism Brain Res Brain Res Protoc 2 1997 75 84
47. A. Saito, K. Miyajima, J. Akatsuka, H. Kondo, T. Mashiko, and T. Kiuchi CaMKIIbeta-mediated LIM-kinase activation plays a crucial role in BDNF-induced neuritogenesis Genes Cells 18 2013 533 543
48. M.L. Santoro, V.K. Ota, R.S. Stilhano, P.N. Silva, C.M. Santos, and M.C. Diana Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR) Schizophr Res 157 2014 163 168
49. G. Scardoni, M. Petterlini, and C. Laudanna Analyzing biological network parameters with CentiScaPe Bioinformatics 25 2009 2857 2859
50. A.H. Schapira, E. Bezard, J. Brotchie, F. Calon, G.L. Collingridge, and B. Ferger Novel pharmacological targets for the treatment of Parkinson's disease Nat Rev Drug Discov 5 2006 845 854
51. C.R. Scherzer, A.C. Eklund, L.J. Morse, Z. Liao, J.J. Locascio, and D. Fefer Molecular markers of early Parkinson's disease based on gene expression in blood Proc Natl Acad Sci U S A 104 2007 955 960
52. M. Sedelis, R.K. Schwarting, and J.P. Huston Behavioral phenotyping of the MPTP mouse model of Parkinson's disease Behav Brain Res 125 2001 109 125
53. M.E. Smoot, K. Ono, J. Ruscheinski, P.L. Wang, and T. Ideker Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432
54. C. Song, X.Y. Zhang, and M. Manku Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment J Neurosci 29 2009 14 22
55. L. Soreq, Z. Israel, H. Bergman, and H. Soreq Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients J Neuroimmunol 201-202 2008 227 236
56. L. Soreq, Y. Ben-Shaul, Z. Israel, H. Bergman, and H. Soreq Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways Neurobiol Dis 45 2012 1018 1030
57. C.C. Stolt, P. Lommes, R.P. Friedrich, and M. Wegner Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy Development 131 2004 2349 2358
58. J.S. Tauskela MitoQ - a mitochondria-targeted antioxidant IDrugs 10 2007 399 412
59. M. Terzioglu, and D. Galter Parkinson's disease: genetic versus toxin-induced rodent models FEBS J 275 2008 1384 1391
60. N.P. Visanji, A. Orsi, T.H. Johnston, P.A. Howson, K. Dixon, and N. Callizot PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP + in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease FASEB J 22 2008 2488 2497
61. Y. Wang, Z. Liu, C. Li, D. Li, Y. Ouyang, and J. Yu Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease Evid Based Complement Alternat Med 2012 2012 698531
62. Y. Wang, L. Lin, H. Lai, L.F. Parada, and L. Lei Transcription factor Sox11 is essential for both embryonic and adult neurogenesis Dev Dyn 242 2013 638 653
63. B. Winner, P. Desplats, C. Hagl, J. Klucken, R. Aigner, and S. Ploetz Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model Exp Neurol 219 2009 543 552
64. X. Yu, G.R. He, L. Sun, X. Lan, L.L. Shi, and Z.H. Xuan Assessment of the treatment effect of baicalein on a model of Parkinsonian tremor and elucidation of the mechanism Life Sci 91 2012 5 13
65. Y. Zhang, X. Guo, D. Wang, R. Li, X. Li, and Y. Xu A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma Sci Rep 4 2014 4154
66. M. Zhu, S. Rajamani, J. Kaylor, S. Han, F. Zhou, and A.L. Fink The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils J Biol Chem 279 2004 26846 26857
67. K. Zuberi, M. Franz, H. Rodriguez, J. Montojo, C.T. Lopes, and G.D. Bader GeneMANIA prediction server 2013 update Nucleic Acids Res 41 2013 W115 W122